24.09.12 16:37 Age: 12 yrs
Edward Lehman Legal "China Hand" and LEHMAN, LEE & XU present Recognitions and Enforcement of Arbitration Awards Rendered under CIETAC Rules in China Master
Edward Lehman 雷曼法学博士
Managing Director 董事长
LEHMAN, LEE & XU China Lawyers
雷曼律师事务所
Founder of LehmanBrown
雷曼会计师事务所创办人
This LEHMAN LEE & XU China Lawyers, Trademark Practice Group, will feature Edward Lehman, China's longest serving managing director of any law firm in mainland China (20 years). Edward Lehman was outside counsel to the Chinese Pharmaceutical industry and worked with key decision makers at the Chinese regulatory authorities in the health care industry at the time when the matter was at controversy. Edward Lehman had a "front row seat" was this a case of bullying of Chinese companies? Was this outcome fraud? Was this a "novel judgment" against a foreign invested enterprise? You will be surprised at the outcome of what insights Edward Lehman will provide. This "case study" deals with the China Trademark Office, Chinese SOE's and Chinese laws regulations and policies, and how it has been called by some as a cautionary tale of "fraud", "legal defeat", "bullying", "novel judgement", "trademark infringement case of the century", and Edward Lehman will explain what really happened and what was the outcome for Pfizer, for the Chinese judicial authorities, and the Chinese healthcare authorities. It is a tale that is applicable today for anyone doing business or wishing to do business in China. Few people know better than, Edward Lehman who manages a Chinese law firm, was the outside counsel to the foreign pharmaceutical industry at the time. Edward Lehman also is special in as much as he founded LehmanBrown International Accountants (see http://www.lehmanbrown.biz/http://www.lehmanbrown.biz/www.lehmanbrown.biz) in China and Edward Lehman has been a law lecturer at China University of Politics & Law, and a Board member at Jiaotong University School of Law (Shanghai) where he has lectured on Intellectual Property and Corporate Commercial Law. Edward Lehman will discuss the failure by some multinational companies to realize the significance of controlling the Chinese transliterations and translations of their English-language trademarks in China and establishing ownership of the transliterations and translations.
Was it a case of bullying? Was it a case of fraud? Was it a case of trademark infringement? Or just the misstep but Pfizer's in-house legal counsel at the time costing hundreds of millions of dollars? Edward Lehman will explain the case in detail, complete with hand-outs in Chinese & English, press clippings in China and abroad, and answer the questions was this an infringement judgement? Edward Lehman will answer were American companies bullied? In Pfizer's case, Pfizer does not own the Chinese trademark for "Weige," the name Viagra is known as in China and in the entire Chinese-speaking world. The Chinese media and consumers coined "Weige," after which it was registered by a Chinese company under China's first-to-file rule. Chow will explore Pfizer's missteps and explain how to avoid similar mistakes in the future.
Date: October 15, 2012
Place: China Ministry of Foreign Affairs Liangmaqiao Diplomatic Compound 10-2,
22 Dong Fang Dong Lu, LEHMAN, LEE & XU China Lawyers Building
Cost: 3500 RMB includes hand-outs and case studies in chinese and English
Time: 8.30am to 11.30am (coffee, tea and breakfast included)
Attendees limited to 25 with priority to LEHMAN, LEE & XU China Lawyers' clients
To reserve send to Edward Lehman email elehman@lehmanlaw.com
For more information on LEHMAN, LEE & XU China Lawyers see http://www.lehmanlaw.com/
For more information on LEHMAN, LEE & XU Mongolian Lawyers see http://www.lehmanlaw.mn/
For more information on LehmanBrown International Accountants seehttp://www.lehmanbrown.biz
China Accounting needs email mail@lehmanbrown.biz
